Back to Authors

Cutrer, F. Michael

https://orcid.org/0000-0002-9869-3700

Mayo Clinic

Mayo Clinic

Citations 29

Numbness matters: A clinical review of trigeminal neuropathy
Smith, Jonathan Helmsley, Cutrer, F. Michael

Cephalalgia | May 31, 2011 | Volume: 31 | Issue: 10 | Pages: 1131-1144

10.1177/0333102411411203 Get It

Aim: Trigeminal neuropathies are a group of clinical disorders that involve injury to primary first-order neurons within the trigeminal nerve. We review the spectrum of etiologies underlying both painful and non-painful trigeminal neuropathies, with attention to particularly dangerous processes that may elude the clinician in the absence of a meticulous evaluation. Complications and management issues specific to patients with trigeminal neuropathy are discussed. Methods: Retrospective literature review. Results: Facial or intraoral numbness, the hallmark of trigeminal neuropathy, may represent the earliest symptomology of malignancy or autoimmune connective tissue disease as sensory neurons are destroyed. Such numbness, especially if progressive, necessitates periodic evaluation and vigilance even years after presentation if no diagnosis can be made. Conclusions: In the routine evaluation of patients with facial pain, the clinician will inevitably be confronted with secondary pathology of the trigeminal nerves and nuclei. The appearance of numbness, even when pain continues to be the most pressing complaint, necessitates clinical assessment of the integrity of all aspects of the trigeminal pathways, which may also include neurophysiologic, radiographic, and laboratory evaluation.
Calcitonin gene related peptide (CGRP)–provoked migraine-like attacks
Cutrer, F. Michael , Mathew, Paul G.

Cephalalgia | September 20, 2010 | Volume: 30 | Issue: 10 | Pages: 1155-1156

10.1177/0333102410365014 Get It

Clinical translation: Targeting cortical spreading depression
Cutrer, F. Michael

Cephalalgia | March 10, 2010 | Volume: 30 | Issue: 5 | Pages: 515-516

10.1177/0333102409352811 Get It

New Information in Our Evolving Understanding of Migraine Aura and Cortical Spreading Depression
Cutrer, F. Michael

Cephalalgia | September 7, 2009 | Volume: 29 | Issue: 10 | Pages: 1129-1131

10.1111/j.1468-2982.2009.01985.x Get It

Botulinum toxin treatment of cephalalgia alopecia increases substance P and calcitonin gene-related peptide-containing cutaneous nerves in scalp
Cutrer, F. Michael , Sandroni, Paola , Wendelschafer‐Crabb, Gwen

Cephalalgia | September 3, 2009 | Volume: 30 | Issue: 8 | Pages: 1000-1006

10.1111/j.1468-2982.2009.01987.x Get It

Pain relief and persistence of dysautonomic features in a patient with hemicrania continua responsive to botulinum toxin type A
Garza, Ivan , Cutrer, F. Michael

Cephalalgia | June 10, 2009 | Volume: 30 | Issue: 4 | Pages: 500-503

10.1111/j.1468-2982.2009.01918.x Get It

Cephalalgic Alopecia Areata
Cutrer, F. Michael , Pittelkow, MR

Cephalalgia | April 3, 2006 | Volume: 26 | Issue: 6 | Pages: 747-751

10.1111/j.1468-2982.2006.01098.x Get It

Cluster Headache with Short-Lived Visual Symptoms
Fattah, QA, Cutrer, F. Michael

Cephalalgia | March 23, 2006 | Volume: 26 | Issue: 4 | Pages: 492-493

10.1111/j.1468-2982.2006.01052.x Get It

Secondary SUNCT Due to Intraorbital, Metastatic Bronchial Carcinoid
Black, DF, Swanson, JW , Eross, EJ, Cutrer, F. Michael

Cephalalgia | July 19, 2005 | Volume: 25 | Issue: 8 | Pages: 633-635

10.1111/j.1468-2982.2005.00917.x Get It